(19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one

C42H58ClN5O6S — CID 146790452

IUPAC(19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one
SMILESC=CC(=O)N1CCN2CCN(CC3(O)CCC[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c4ccc5c(c4)N(CCCCc4cc(Cl)ccc4CO5)C[C@@H]4CC[C@H]43)C[C@H]2C1
InChIInChI=1S/C42H58ClN5O6S/c1-4-40(49)48-21-20-46-19-18-45(25-36(46)26-48)28-42(51)16-7-8-29(2)30(3)55(52,53)44-41(50)32-12-15-39-38(23-32)47(24-33-11-14-37(33)42)17-6-5-9-31-22-35(43)13-10-34(31)27-54-39/h4,10,12-13,15,22-23,29-30,33,36-37,51H,1,5-9,11,14,16-21,24-28H2,2-3H3,(H,44,50)/t29-,30+,33-,36-,37+,42?/m0/s1
InChIKeyRVSLNLRXGPHGRE-HMNJAZRISA-N
MW796.48 g/mol
LogP5.10
Rot. Bonds3

About (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one

(19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one (PubChem CID 146790452) has the molecular formula C42H58ClN5O6S and a molecular weight of 796.48 g/mol. Its IUPAC name is (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one.

Molecular Properties

Compound Name(19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one
PubChem CID146790452
Molecular FormulaC42H58ClN5O6S
Molecular Weight796.48 g/mol
Exact Mass795.38
IUPAC Name(19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one
SMILESC=CC(=O)N1CCN2CCN(CC3(O)CCC[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c4ccc5c(c4)N(CCCCc4cc(Cl)ccc4CO5)C[C@@H]4CC[C@H]43)C[C@H]2C1
InChIInChI=1S/C42H58ClN5O6S/c1-4-40(49)48-21-20-46-19-18-45(25-36(46)26-48)28-42(51)16-7-8-29(2)30(3)55(52,53)44-41(50)32-12-15-39-38(23-32)47(24-33-11-14-37(33)42)17-6-5-9-31-22-35(43)13-10-34(31)27-54-39/h4,10,12-13,15,22-23,29-30,33,36-37,51H,1,5-9,11,14,16-21,24-28H2,2-3H3,(H,44,50)/t29-,30+,33-,36-,37+,42?/m0/s1
InChIKeyRVSLNLRXGPHGRE-HMNJAZRISA-N
XLogP5.10
TPSA122.73 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds3
Heavy Atoms55
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500796.48
LogP ≤ 55.10
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one?
The IUPAC name of (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one (CID 146790452) is (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one.
What is the SMILES notation for (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one?
The canonical SMILES for (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one is C=CC(=O)N1CCN2CCN(CC3(O)CCC[C@H](C)[C@@H](C)S(=O)(=O)NC(=O)c4ccc5c(c4)N(CCCCc4cc(Cl)ccc4CO5)C[C@@H]4CC[C@H]43)C[C@H]2C1.
What is the InChIKey of (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one?
The InChIKey is RVSLNLRXGPHGRE-HMNJAZRISA-N. The full InChI is InChI=1S/C42H58ClN5O6S/c1-4-40(49)48-21-20-46-19-18-45(25-36(46)26-48)28-42(51)16-7-8-29(2)30(3)55(52,53)44-41(50)32-12-15-39-38(23-32)47(24-33-11-14-37(33)42)17-6-5-9-31-22-35(43)13-10-34(31)27-54-39/h4,10,12-13,15,22-23,29-30,33,36-37,51H,1,5-9,11,14,16-21,24-28H2,2-3H3,(H,44,50)/t29-,30+,33-,36-,37+,42?/m0/s1.
What are the key properties of (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one?
(19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one has a molecular weight of 796.48 g/mol, XLogP of 5.10, 3 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (19R,22R,27S,28R)-23-[[(9aS)-2-prop-2-enoyl-3,4,6,7,9,9a-hexahydro-1H-pyrazino[1,2-a]pyrazin-8-yl]methyl]-10-chloro-23-hydroxy-27,28-dimethyl-29,29-dioxo-5-oxa-29λ6-thia-17,30-diazapentacyclo[15.14.2.04,33.07,12.019,22]tritriaconta-1(32),2,4(33),7(12),8,10-hexaen-31-one is sourced from PubChem (CID 146790452), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).